VRTX Retained Earnings
Vertex Pharmaceuticals · Retained Earnings
VRTX Retained Earnings
Latest reported$13.56Bperiod ending
VRTX FY Retained Earnings (-$6.20M → $13.56B)
Annual retained earnings
High-resolution chart · PNG
VRTX retained earnings history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Retained Earnings (USD) |
|---|---|
| 13,560,000,000 | |
| 9,606,800,000 | |
| 10,142,400,000 | |
| 6,522,800,000 | |
| 3,200,800,000 | |
| 858,669,000 | |
| -1,852,978,000 | |
| -2,989,478,000 | |
| -5,119,723,000 | |
| -5,373,836,000 | |
| -5,261,784,000 | |
| -4,705,450,000 | |
| -3,966,895,000 | |
| -3,521,867,000 | |
| -3,414,835,000 | |
| -3,444,409,000 | |
| -2,689,783,000 | |
| -2,047,605,000 | |
| -1,587,754,000 | |
| -1,196,475,000 | |
| -989,584,000 | |
| -786,167,000 | |
| -619,920,000 | |
| -423,153,000 | |
| -314,532,000 | |
| -230,485,000 | |
| -190,800,000 | |
| -149,900,000 | |
| -116,800,000 | |
| -96,900,000 | |
| -56,900,000 | |
| -35,400,000 | |
| -17,800,000 | |
| -19,900,000 | |
| -11,400,000 | |
| -6,200,000 |